Harbour Investments’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.14K Buy
438
+116
+36% +$1.56K ﹤0.01% 3498
2025
Q4
$3.62K Sell
322
-48
-13% -$549 ﹤0.01% 3137
2025
Q3
$4.28K Hold
370
﹤0.01% 3043
2025
Q2
$4.53K Hold
370
﹤0.01% 2916
2025
Q1
$5.3K Sell
370
-18
-5% -$281 ﹤0.01% 2807
2024
Q4
$6.18K Buy
388
+18
+5% +$356 ﹤0.01% 2651
2024
Q3
$8.89K Buy
370
+41
+12% +$937 ﹤0.01% 2402
2024
Q2
$6.55K Hold
329
﹤0.01% 2419
2024
Q1
$6.55K Sell
329
-1,082
-77% -$20.9K ﹤0.01% 2370
2023
Q4
$31.6K Buy
1,411
+1,082
+329% +$22.3K ﹤0.01% 1660
2023
Q3
$6.65K Buy
329
+20
+6% +$453 ﹤0.01% 2186
2023
Q2
$7.9K Sell
309
-42
-12% -$1.11K ﹤0.01% 2139
2023
Q1
$10.4K Hold
351
﹤0.01% 1997
2022
Q4
$9.5K Buy
351
+25
+8% +$611 ﹤0.01% 1972
2022
Q3
$9K Hold
326
﹤0.01% 1952
2022
Q2
$9K Buy
+326
New +$9.37K ﹤0.01% 1952
2021
Q4
$2K Sell
51
-772
-94% -$25K ﹤0.01% 2369
2021
Q3
$26K Buy
823
+26
+3% +$882 ﹤0.01% 2148
2021
Q2
$29K Buy
797
+9
+1% +$372 ﹤0.01% 2112
2021
Q1
$35K Buy
+788
New +$37K ﹤0.01% 1877

Other funds holding AVNS

Harbour Investments's AVNS Position: Q1 2026 in Review

Harbour Investments increased its Avanos Medical (AVNS) stake by 36% in Q1 2026, buying an estimated $1.56K and bringing the position to 438 shares worth $6.14K. The position accounts for ﹤0.01% of the portfolio, ranked #3498.

Harbour Investments first reported a position in AVNS in Q1 2021 and has held it in 20 quarters since. The position peaked at $35K in Q1 2021. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Harbour Investments held 438 shares of Avanos Medical worth $6.14K as of Q1 2026.
  • Harbour Investments bought 116 Avanos Medical shares in Q1 2026, an estimated $1.56K.
  • Avanos Medical made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3498 holding.
  • Harbour Investments first reported a position in Avanos Medical in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Avanos Medical position peaked at $35K in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.